John D. Shulman - Oct 18, 2021 Form 4 Insider Report for Petros Pharmaceuticals, Inc. (PTPI)

Role: Director, 10%+ Owner
Signature: [see signatures attached as Exhibit 99.2]
Stock symbol: PTPI
Transactions as of: Oct 18, 2021
Transactions value $: $2,849,999
Form type: 4
Date filed: 10/21/2021, 08:47 AM
Next filing: Nov 30, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PTPI	Common Stock, par value $0.0001 per share	Purchase	$2.85M	+1.66M	+48.93%	$1.72	5.06M	Oct 18, 2021	See Footnote	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PTPI	Warrant	Purchase	$0	+1.66M		$0.00	1.66M	Oct 18, 2021	Common Stock	1.66M	$1.72	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	See Note (1) in Exhibit 99.1.
F2	Includes 185,414 shares of Common Stock previously held of record by Metuchen Therapeutics, LLC ("MT") that were received by JCP III SM AIV, L.P. as a liquidating distribution. In prior reports, the reporting persons beneficially owned the 185,414 previously held by MT.